Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise
Via Benzinga
Exposures Product Safety
Tickers BHVN
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Participate in Global Conference with Three TNX-102 SL Data Presentations
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TNXP
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval
Via Benzinga
Exposures Product Safety
Tickers SNY
BOQU Instrument Elevates Professional Standards in Water Quality Sensors and Analyzers
Via AB Newswire
Topics Intellectual Property Supply Chain
Exposures Intellectual Property Product Safety Supply Chain
Approved for Domestic Market, OT-1001 Ushers in a New Era for Pediatric Allergic Conjunctivitis Treatment
Via AB Newswire
Exposures Product Safety
Burning Daily Announces Enhanced Brand Selection Standards to Ensure Premium Products for Customers.
Via GetFeatured
Topics Supply Chain
Exposures Product Safety Supply Chain
ICU Medical Recalls ParaPAC Plus Ventilators Due To Loose Outlet Connector That Can Cause Injury Or Death
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers ICUI
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
Via Benzinga
Exposures Product Safety
Tickers ABBV BMY
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
Via Benzinga
Exposures Product Safety
Tickers JNJ
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
Via Benzinga
Exposures Product Safety
Tickers JNJ ZVRA
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
Via Benzinga
Exposures Product Safety
Tickers ELAN ZTS
GM To Recall Nearly 450K Vehicles Over Inoperative Warning Lights On Loss Of Brake Fluid
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers GM
ICU Medical Recalls Certain Tracheostomy Tubes Due To Manufacturing Defects
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers ICUI
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Awarded Patent Covering Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers TNXP
FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies
Via Benzinga
Exposures Product Safety
Tickers VNDA
Robert Kennedy Jr: Trump Wants Him To Help Pick CDC, FDA, and NIH Leaders — 'Unravel The Capture Of Agencies By Corrupt Influence'
Via Benzinga
Topics Government
Exposures Political Product Safety
Flipping the Script on LBPs: Creative Biolabs Delivers Game-Changing Analytical Services
Via Get News
Exposures Product Safety
Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks
Via Benzinga
Exposures Product Safety
Tickers ZBH
Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer
Via Benzinga
Exposures Product Safety
Tickers MRK
AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation
Via Benzinga
Exposures Product Safety
Tickers AZN GSK
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug
Via Benzinga
Exposures Product Safety
Tickers APLT
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) TNX-801 Positioned as Viable Contender in Global Fight Against Mpox
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
Via Benzinga
Exposures Product Safety
Tickers VVOS
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Awarded First-Ever FDA Clearance for Pediatric Treatment of Sleep Apnea, Snoring
Via Investor Brand Network
Exposures Product Safety
Tickers VVOS
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
Via Benzinga
Exposures Product Safety
Tickers AGEN GSK
Top-Rated Hartford-Based Firm, Freed Marcroft Divorce & Family Law, Name Two Talented Team Members As Partner
Via Syndication Cloud
Topics Product Recall
Exposures Legal Product Safety
Why 3D Systems (DDD) Stock Is Trading Higher
Via Benzinga
Exposures Product Safety
Tickers DDD
The only FDA-approved nasal spray medication proven to reduce symptoms in people living with treatment-resistant depression
Via Brandpoint
Exposures Product Safety
Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss
Via Benzinga
Exposures Product Safety
Tickers LLY
Creative Diagnostics Announces New Zearalenone Test Reagents for Food Safety Applications
Via AB Newswire
Topics Supply Chain
Exposures Ethanol Product Safety Supply Chain
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.